AVR 0.00% $18.31 anteris technologies ltd

Ann: Exclusive Supply Agreement with 4C Medical, page-3

  1. 1,543 Posts.
    lightbulb Created with Sketch. 131
    Approximately 7 million people in the U.S., suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffer from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation. The number of new patients suffering with mitral regurgitation disease added each year is 250,000. Among this 4.1 million patients, only about 20% or 1.67 million are eligible for the treatment. This creates huge opportunity for the global transcatheter mitral valve replacement market.

    http://www.prnewswire.com/news-rele...-trends-and-forecast-2014-2022-300435461.html
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
0.000(0.00%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.30 $19.00 $18.00 $363.4K 19.82K

Buyers (Bids)

No. Vol. Price($)
2 500 $18.13
 

Sellers (Offers)

Price($) Vol. No.
$18.50 1000 1
View Market Depth
Last trade - 15.59pm 01/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.